Analysts expect Endo International plc (NASDAQ:ENDP) (TSE:ENL) to post earnings per share of $0.54 for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have provided estimates for Endo International’s earnings. The highest EPS estimate is $0.60 and the lowest is $0.49. Endo International reported earnings of $0.93 per share during the same quarter last year, which indicates a negative year-over-year growth rate of 41.9%. The firm is scheduled to issue its next earnings report on Tuesday, August 14th.
According to Zacks, analysts expect that Endo International will report full year earnings of $2.36 per share for the current year, with EPS estimates ranging from $2.24 to $2.48. For the next year, analysts anticipate that the company will post earnings of $2.51 per share, with EPS estimates ranging from $2.29 to $2.95. Zacks’ EPS calculations are an average based on a survey of sell-side research analysts that that provide coverage for Endo International.
Endo International (NASDAQ:ENDP) (TSE:ENL) last announced its earnings results on Tuesday, May 8th. The company reported $0.67 earnings per share for the quarter, beating the consensus estimate of $0.55 by $0.12. Endo International had a positive return on equity of 143.46% and a negative net margin of 75.58%. The firm had revenue of $700.53 million during the quarter, compared to the consensus estimate of $691.94 million. During the same quarter in the prior year, the company earned $1.23 EPS. The firm’s revenue for the quarter was down 32.5% compared to the same quarter last year.
Hedge funds have recently made changes to their positions in the business. Paloma Partners Management Co bought a new stake in shares of Endo International in the 4th quarter worth approximately $122,000. Oakbrook Investments LLC bought a new stake in shares of Endo International in the 4th quarter worth approximately $133,000. Xact Kapitalforvaltning AB bought a new stake in shares of Endo International in the 4th quarter worth approximately $157,000. Elkfork Partners LLC bought a new stake in shares of Endo International in the 4th quarter worth approximately $194,000. Finally, Nisa Investment Advisors LLC bought a new stake in shares of Endo International in the 4th quarter worth approximately $236,000. Institutional investors own 98.38% of the company’s stock.
NASDAQ:ENDP traded up $0.23 during mid-day trading on Friday, hitting $6.18. 150,538 shares of the company’s stock traded hands, compared to its average volume of 5,113,884. Endo International has a 12 month low of $5.27 and a 12 month high of $14.15. The company has a market cap of $1.34 billion, a price-to-earnings ratio of 1.61 and a beta of 0.34. The company has a quick ratio of 0.88, a current ratio of 1.06 and a debt-to-equity ratio of -1,161.84.
About Endo International
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.